Topic: clinical-grade production mscs

Stem Cell Startup Hits Key Milestone for Mass-Produced Medicine

Stem cell therapy, led by Swedish startup Cellcolabs, is advancing toward mass production of mesenchymal stem cells (MSCs), which can repair tissues and reduce inflammation, but scaling remains a challenge. Cellcolabs has achieved a breakthrough by producing 4.1 billion MSCs from a single donatio...